Yale University, Alzheimer's Disesase Research Unit — New Haven, Connecticut

Yale University, Alzheimer's Disesase Research Unit is a clinical research site located in New Haven, Connecticut, United States.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Yale University, Alzheimer's Disesase Research Unit has participated in 1 clinical trials.

Therapeutic areas: Alzheimer Disease.

Sponsors: Bellus Health Inc. - a GSK company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University, Alzheimer's Disesase Research Unit?

Yale University, Alzheimer's Disesase Research Unit has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University, Alzheimer's Disesase Research Unit conducted?

Yale University, Alzheimer's Disesase Research Unit has 1 clinical trials on record. Their work covers Alzheimer Disease.

Is Yale University, Alzheimer's Disesase Research Unit accredited by Crixeo Health?

Yale University, Alzheimer's Disesase Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University, Alzheimer's Disesase Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.